James Daniel Meyer

US Patent:

6962016, Nov 8, 2005

Filed:

Oct 2, 2003

Appl. No.:

10/676653

Inventors:

James F. Meyer - Stover MO, US

International Classification:

A47G001/16

US Classification:

40757, 40700

Abstract:

A picture frame and hanger bar together provide a picture hanging system that requires a single hanger bar in addition to the picture frame itself. The picture frame hanger has a wall mounting surface that during use is affixed to the wall or other vertical surface and the picture frame is provided with a downwardly facing skid member that is recessed within a pocket in the rear of the picture frame. The hanger bar is provided with an upwardly facing ramp surface that is canted downwardly proceeding toward the wall so that when the skid on the picture frame engages the canted surface, the picture frame will slide rearwardly toward the wall on the canted surface so as to press the picture frame against the wall by the force of gravity. The hanger bar preferably applies pressure to a backer board positioned behind the picture or other graphic article for holding it in a flat condition.

US Patent:

20120040048, Feb 16, 2012

Filed:

Mar 3, 2010

Appl. No.:

13/254833

Inventors:

James H. Meyer - Santa Monica CA, US

Assignee:

Meyer Nutriceuticals, LLC - Santa Monica CA

International Classification:

A23L 1/00

US Classification:

426 2, 426 89

Abstract:

Correctly formulated enterically coated nutrient pellets are able to significantly to lower the blood sugar level of type two diabetics when administered with a normal meal. The inventive composition is effective at dosage levels of 10 g or less. Effective doses of the composition contribute 42 kcal or fewer to the patient's diet. A preferred form of the composition contains lauric acid coated for release in the distal bowel. When taken with an ordinary meal, the effective dosage does not induce the ileal brake and is more than 50 times (often more than 100 times) as effective on per kilocalorie basis as an ordinary meal at eliciting increases in PYY and GLP-1. Thus, ordinary nutrients—as opposed to drugs—can be used to reduce blood sugar levels when administered at dosage levels that are not significant promoters of weight gain.

US Patent:

62679880, Jul 31, 2001

Filed:

May 19, 1998

Appl. No.:

9/081045

Inventors:

James H. Meyer - Santa Monica CA

International Classification:

A61K 914

US Classification:

424489

Abstract:

A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingredient may include sugars, fatty acids, polypeptides, and amino acids. The delivery agent may be a pH sensitive coating, a cellulosic polymer coating or a diazotized polymer. The composition may be formulated into pellets of between 1 and 3 mm with a density of around 1. The composition may be administered with a liquid as a slurry, or it may be administered in a tablet form. The composition may be used in conjunction with any weight loss or weight maintenance program.

US Patent:

49769499, Dec 11, 1990

Filed:

Jan 29, 1990

Appl. No.:

7/474633

Inventors:

James H. Meyer - Santa Monica CA
Gordon L. Amidon - Ann Arbor MI
Jennifer B. Dressman - Ann Arbor MI

Assignee:

The University of Michigan - Ann Arbor MI

International Classification:

A61K 922
G01N 3700

US Classification:

424 11

Abstract:

A dosage system for administering drugs and conducting gastric flow studies is configured in the form of a multiplicity of substantially spherical subunits which have advantageously preselected particle diameter and density to customize the flow rate of the subunits with respect to the rate of flow of at least certain portions of the chyme. The diameter and density are related to one another in accordance with a relationship: ##EQU1## where N. sub. V is a dimensionless group having a predetermined value representing gastric residence time, g is the gravitational constant,. DELTA. p is the difference in density between the subunits and the chyme, and is the linear velocity of the chyme. The flow rate of the subunits can be made slower, faster, or substantially equal to that of the chyme, as required to treat certain disease states. Also, the subunits can be provided with an enteric coating which permits more precise administration of certain drugs, such as those used in enzyme supplementation therapy.

US Patent:

53226976, Jun 21, 1994

Filed:

May 28, 1992

Appl. No.:

7/889710

Inventors:

James H. Meyer - Santa Monica CA

International Classification:

A61K 954
A61K 962
A61K 31195
A61K 3700

US Classification:

424458

Abstract:

A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingredient may include sugars, fatty acids, polypeptides, and amino acids. The delivery agent may be a pH sensitive coating, a cellulosic polymer coating or a diazotized polymer. The composition may be formulated into pellets of between 1 and 3 mm with a density of around 1. The composition may be administered with a liquid as a slurry, or it may be administered in a tablet form. The composition may be used in conjunction with any weight loss or weight maintenance program.

US Patent:

57532532, May 19, 1998

Filed:

Jun 21, 1994

Appl. No.:

8/263349

Inventors:

James H. Meyer - Santa Monica CA

International Classification:

A61K 910
A61K 914
A61K 926
A61K 31195

US Classification:

424439

Abstract:

A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingredient may include sugars, fatty acids, polypeptides, and amino acids. The delivery agent may be a pH sensitive coating, a cellulosic polymer coating or a diazotized polymer. The composition may be formulated into pellets of between 1 and 3 mm with a density of around 1. The composition may be administered with a liquid as a slurry, or it may be administered in a tablet form. The composition may be used in conjunction with any weight loss or weight maintenance program.

US Patent:

62595725, Jul 10, 2001

Filed:

Feb 21, 1996

Appl. No.:

8/604340

Inventors:

James E. Meyer - Los Angeles CA

Assignee:

Rosco Laboratories, Inc. - Port Chester NY

International Classification:

G02B 522
G03B 1502

US Classification:

359885

Abstract:

A photographic color effects lighting filter system made up of a series of lighting filters which are designed to be placed in front of one or more lighting sources. The lighting color effects filter series is made up of groups of filters wherein each of the filter groups is composed of a plurality of filters wherein each filter within a given group provides selective absorption of light having a color corresponding to one of the primary, secondary or intermediary colors. Each of the filters within a given group has a specific effective absorption density. The effective absorption densities are calibrated so that the selected absorption densities are the same for each of the different color groups.

US Patent:

20150290162, Oct 15, 2015

Filed:

Apr 14, 2015

Appl. No.:

14/686606

Inventors:

- Santa Monica CA, US
James H. Meyer - Santa Monica CA, US

Assignee:

MEYER NUTRICEUTICALS, LLC - Santa Monica CA

International Classification:

A61K 31/20
A23L 1/29
A61K 9/50

Abstract:

Correctly formulated enterically coated nutrient pellets are able to significantly to lower the blood sugar level of type two diabetics when administered with a normal meal. The inventive composition is effective at dosage levels of 10 g or less. Effective doses of the composition contribute 42 kcal or fewer to the patient's diet. A preferred form of the composition contains lauric acid coated for release in the distal bowel. When taken. with an ordinary meal, the effective dosage does not induce the ileal brake and is more than 50 times (often more than 100 times) as effective on per kilocalorie basis as an ordinary meal at eliciting increases in PYY and GLP-1. Thus, ordinary nutrients—as opposed to drugs—can be used to reduce blood sugar levels when administered at dosage levels that are not significant promoters of weight gain.